documents: FDA-2012-D-0307-0063
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2012-D-0307-0063 | FDA | FDA-2012-D-0307 | Recommendations To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt Jakob Disease by Blood and Blood Components; Guidance for Industry; Availability; | Notice | Notice of Availability | 2020-06-17T04:00:00Z | 2020 | 6 | 2020-06-17T04:00:00Z | 2020-06-17T12:33:02Z | 2020-13055 | 0 | 0 | 09000064846f5d22 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref